ProKidney Corp. (PROK)
NASDAQ: PROK · Real-Time Price · USD
1.500
-0.020 (-1.32%)
Feb 21, 2025, 4:00 PM EST - Market closed
ProKidney Employees
ProKidney had 163 employees as of December 31, 2023. The number of employees increased by 76 or 87.36% compared to the previous year.
Employees
163
Change (1Y)
76
Growth (1Y)
87.36%
Revenue / Employee
n/a
Profits / Employee
-$279,810
Market Cap
437.49M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 163 | 76 | 87.36% |
| Dec 31, 2022 | 87 | 28 | 47.46% |
| Dec 31, 2021 | 59 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
PROK News
- 22 days ago - Kuehn Law Encourages Investors of ProKidney Corp. to Contact Law Firm - PRNewsWire
- 22 days ago - 2025 Will Be A Major Year For ProKidney's Rilparencel In CKD Treatment - Seeking Alpha
- 3 months ago - ProKidney to Participate in Two Upcoming Conferences: Evercore HealthCONx Conference and the Citi Global Healthcare Conference - GlobeNewsWire
- 3 months ago - ProKidney Reports Third Quarter 2024 Financial Results along with Regulatory and Clinical Development Updates Following Successful FDA Type B Meeting - GlobeNewsWire
- 3 months ago - ProKidney to Participate in the Guggenheim Inaugural Healthcare Innovation Conference and the Jefferies London Healthcare Conference - GlobeNewsWire
- 4 months ago - ProKidney Announces Five Abstracts Selected for Presentation at the American Society of Nephrology's Kidney Week 2024 - GlobeNewsWire
- 4 months ago - ProKidney to Participate in the UBS Virtual Organ Restoration Day - GlobeNewsWire
- 6 months ago - ProKidney Announces Strategic Updates to its Phase 3 Program to Accelerate Rilparencel's Registrational Path to Potential Approval in the U.S. - GlobeNewsWire